With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Researchers have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies.

According to the Centers for Disease Control and Prevention, at least 450,000 people in the US have alpha-gal syndrome - a ...

A KILDARE man is running his first ever marathon in honour of his “incredible” wife who was diagnosed with end stage kidney ...

After years of symptoms and misdiagnoses, one patient shares how he learned he had a life-altering condition that challenges ...

Detailed price information for Lisata Therapeutics Inc (LSTA-Q) from The Globe and Mail including charting and trades.

A hypothyroidism diagnosis doesn’t have to feel daunting. Experts share the essential first steps to take to support your health.

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...

Fact: The flu vaccine is an inactive (killed) form of the flu virus that helps your body build up antibodies so they’re ready ...

Leixlip, Co Kildare plumber Stephen Rubotham has signed up to raise funds for the Irish Kidney Association in honour of his ...

Zocilurtatug pelitecan (zoci), also known as ZL-1310, an investigational antibody-drug conjugate (ADC) that targets the ...